Lexaria Bioscience Statistics Share Statistics Lexaria Bioscience has 19.56M
shares outstanding. The number of shares has increased by 23.24%
in one year.
Shares Outstanding 19.56M Shares Change (YoY) 23.24% Shares Change (QoQ) 11% Owned by Institutions (%) 7.08% Shares Floating 17.96M Failed to Deliver (FTD) Shares 2,719 FTD / Avg. Volume 1.95%
Short Selling Information The latest short interest is 526.38K, so 2.69% of the outstanding
shares have been sold short.
Short Interest 526.38K Short % of Shares Out 2.69% Short % of Float 2.99% Short Ratio (days to cover) 6.54
Valuation Ratios The PE ratio is -8.36 and the forward
PE ratio is -1.76.
Lexaria Bioscience's PEG ratio is
0.16.
PE Ratio -8.36 Forward PE -1.76 PS Ratio 104.29 Forward PS 20.5 PB Ratio 6.03 P/FCF Ratio -9.68 PEG Ratio 0.16
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lexaria Bioscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.18,
with a Debt / Equity ratio of 0.02.
Current Ratio 7.18 Quick Ratio 7.18 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $66.33K Profits Per Employee $-827.91K Employee Count 7 Asset Turnover 0.05 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -74.92% in the
last 52 weeks. The beta is 0.79, so Lexaria Bioscience's
price volatility has been higher than the market average.
Beta 0.79 52-Week Price Change -74.92% 50-Day Moving Average 0.93 200-Day Moving Average 1.56 Relative Strength Index (RSI) 41.86 Average Volume (20 Days) 139,559
Income Statement In the last 12 months, Lexaria Bioscience had revenue of 464.28K
and earned -5.8M
in profits. Earnings per share was -0.47.
Revenue 464.28K Gross Profit 459.46K Operating Income -5.75M Net Income -5.8M EBITDA -5.68M EBIT -5.75M Earnings Per Share (EPS) -0.47
Full Income Statement Balance Sheet The company has 6.5M in cash and 137.37K in
debt, giving a net cash position of 6.36M.
Cash & Cash Equivalents 6.5M Total Debt 137.37K Net Cash 6.36M Retained Earnings -51.56M Total Assets 6.74M Working Capital 4.32M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.96M
and capital expenditures -43.02K, giving a free cash flow of -5M.
Operating Cash Flow -4.96M Capital Expenditures -43.02K Free Cash Flow -5M FCF Per Share -0.4
Full Cash Flow Statement Margins Gross margin is 98.96%, with operating and profit margins of -1239.16% and -1248.25%.
Gross Margin 98.96% Operating Margin -1239.16% Pretax Margin -1251.12% Profit Margin -1248.25% EBITDA Margin -1222.75% EBIT Margin -1239.16% FCF Margin -1077.38%
Dividends & Yields LEXX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for LEXX is $4,
which is 387.8% higher than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference 387.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 12, 2021. It was a
backward
split with a ratio of 1:30.
Last Split Date Jan 12, 2021 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -11.04 Piotroski F-Score 2
